Patient Information:
- Name: Mr. Li
- Diagnosis: Type II Diabetes Mellitus
- Date of Birth (D.O.B): August 1, 1956
- Gender: Male
- Country: China
Treatment: Cellular Immune Therapy for Type II Diabetes combined with Nerve Growth Factor Treatment, Physical Therapy, Traditional Chinese Medicine (TCM), and Metabolic Control Management at Beijing Puhua International Hospital (BPIH)
Medical History:
Mr. Li was admitted to BPIH due to Type II Diabetes of eight years duration.
Medical Condition before Cellular Immune Therapy for Type II Diabetes:
- Symptoms:
- Insulin dependence: injections before meals daily
- Poor sleep quality
- Abnormal thirst
- Nocturia
- Blurred vision
- Medications:
- Metformin
- Phenformin
- Insulin injections
- Laboratory Results (admission):
- HbA1c: 9.5%
- Fasting Blood Glucose (FBG): 14.0 mmol/L (252 mg/dL)
- Postprandial Blood Glucose (PBG): 25.9 mmol/L (467 mg/dL)
Cellular Immune Therapy for Type II Diabetes:
- Medical protocols applied:
- Cellular immune therapy to repair injured pancreatic islet cells
- Metabolic function improvement and blood sugar control management
- Traditional Chinese medicine (TCM)
- Rehabilitation therapy
Physical Condition after Cellular Immune Therapy for Type II Diabetes (post-therapy):
- Improved laboratory results:
- HbA1c: 7.6%
- FBG: 9.4 mmol/L (170 mg/dL) – a decrease of 4.6 mmol/L (82 mg/dL)
- PBG: 10.0 mmol/L (180 mg/dL) – a decrease of 15.9 mmol/L (287 mg/dL)
- Successful insulin discontinuation
- Improved oral medications for blood sugar control only
- Improved sleep quality
- Significant alleviation of symptoms:
- Abnormal thirst
- Nocturia
- Blurred vision
